Ask yourself how the genetic test results may affect your life. If the results come back positive, will you take steps to ...

Oncologists caution that at-home genetic tests taken up by millions of Americans looking to gauge their cancer risk are not ...

Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a cash balance of ...

A molar pregnancy, also known as a hydatidiform mole, is an abnormal human pregnancy with no embryo and an overgrowth of the ...

Major advances made at the RI-MUHC could help improve counselling for individuals suffering from infertility, premature ...

Two patients in Allarity’s Phase 2 clinical trial of stenoparib for advanced, recurrent ovarian cancer have now been on treatment for ... companies now leveraging the Company’s advanced gene ...

"I feel like I have a responsibility to scream and shout loudly about it and say 'hey, this is killing women in Australia'," ...

The second is set to require 20,000 volunteers, constituting the largest melanoma study ever. The third scheme, funded by ...

PlaCCine®, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the ...

The technique of removal and preservation of ovarian tissue, which can later be re-implanted to restore fertility once cancer ...

The firm is now inking revenue-generating contracts with other biotech companies for its drug response prediction and gene expression analysis capabilities.